The incidence and beta-lactam resistance of Proteus vulgaris in hospital infections: the last decade

J Chemother. 1991 Oct;3(5):283-8. doi: 10.1080/1120009x.1991.11739107.

Abstract

During the period of 1980-1990, 581 Proteus vulgaris strains were obtained in a general hospital. They were considered as the significant isolate in 0.6% of soft tissue infections, 0.6% of urinary tract infections and in 0.2% of bacteremic episodes. Sixty-three percent of the 393 tested strains showed resistance to ampicillin, cefazolin and cefamandole or cefuroxime. About 7% were susceptible to all beta-lactam drugs, and showed a very low beta-lactamase activity and 5% of the strains showed a phenotype of resistance including ampicillin, carbenicillin-ticarcillin, cefazolin and cefamandole or cefuroxime, and presented increased chromosomal beta-lactamase activity. Cefotaxime-resistance was detected in 2% of the isolates which appeared in the period 1987-1990.

MeSH terms

  • Ampicillin Resistance
  • Anti-Bacterial Agents / pharmacology*
  • Aztreonam / pharmacology
  • Bacteremia / epidemiology
  • Bacteremia / microbiology*
  • Cephalosporins / pharmacology
  • Cross Infection / microbiology*
  • Drug Resistance, Microbial
  • Humans
  • Microbial Sensitivity Tests
  • Moxalactam / pharmacology
  • Penicillins / pharmacology
  • Phenotype
  • Proteus Infections / epidemiology
  • Proteus Infections / microbiology*
  • Proteus vulgaris / drug effects*
  • Proteus vulgaris / isolation & purification
  • Spain / epidemiology
  • Urinary Tract Infections / epidemiology
  • Urinary Tract Infections / microbiology*
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Penicillins
  • beta-Lactamases
  • Aztreonam
  • Moxalactam